Diligence memo · auto-generated · as of July 2, 2026
IsoBio, Inc.
IsoBio, Inc. looks fair against its niche peers and is active on financing cadence.
Businessfiled
IsoBio, Inc. operates in Other Health Care, based in GLADWYNE.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
IsoBio, Inc. has raised $1.7M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $1.7M on 2025-10-21.
Most recent recorded round closed around 2025-10-21.
Valuation (modeled)modeled
Provath models IsoBio, Inc. at approximately $4.4M (range $1.5M–$8.2M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.03× the median modeled value of Seed Other Health Care companies in 2025–2027 (105 peers) — value vs value, same stage and era. Within the normal band (103% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 8 mo ago; this sector typically re-raises about every 14 months.
Raising on or ahead of the sector's normal rhythm.
Comparablesmixed
Capital scale ranks ahead of 44% of Other Health Care peers (5377 compared).
Modeled value ranks above 19% of those peers.
Closest niche peers: Xymogen, Inc., Willow Life Sciences, Inc., ManyClicks, Inc., Sterile State, Inc., Limber Prosthetics, Inc..
Peoplefiled
3 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.